UnitedHealth Experiences Stock Surge
Shares of UnitedHealth (NYSE: UNH) rose by 3% during the afternoon session, continuing an upward trend fueled by positive news that alleviated concerns among investors. The company reported an improved Medicare Advantage Star rating and confirmed its earnings expectations for 2025.
The announcement indicated that about 78% of Medicare Advantage members are projected to receive a plan rated 4 stars or higher by 2026, which is a significant improvement from the 69% expected for 2025. Furthermore, UnitedHealth has reaffirmed its forecast of at least $16 in earnings per share for the fiscal year 2025, which includes the impact of its recent Amedisys acquisition. This news relieved anxious investors who were worried about potential downgrades in guidance and how the star rating might affect future revenue. The stock’s positive trajectory continued following a surge following prior announcements.
After an initial spike, the stock settled at $354.43, reflecting a 2.1% increase from the previous close.
So, is this the moment to invest in UnitedHealth? Perhaps it’s worth considering, though the stock has been quite volatile, with more than 20 instances of 5% fluctuations last year. Today’s movements suggest that the market finds this information significant, but it doesn’t drastically alter the overall perception of the company.
Just recently, there was another notable spike when the stock gained 4.7% following good news about its Medicare Advantage business and reaffirmation of its 2025 revenue guidance.
In a regulatory filing, UnitedHealth noted that about 78% of its Medicare Advantage members are anticipated to enroll in plans rated four stars or higher, based on initial assessments. This rating is crucial, as qualifying for the government’s star rating system can lead to valuable bonus payments, directly impacting the company’s revenue. Investors are feeling more confident, especially with the positive outlook for Medicare and the company’s commitment to its adjusted revenue forecast for 2025.
However, it’s worth mentioning that UnitedHealth’s stock has decreased by 29.7% since the beginning of the year, currently trading at $354.43 per share, which is 43.3% below its 52-week high of $625.25 reached in November 2024.
At Stockstory, we recognize the potential of thematic investments. Recognizing diverse winners, like Microsoft (MSFT), Alphabet (GOOGL), Coca-Cola (KO), and Monster Beverage (MNST), we’re always on the lookout for promising growth stories. In that vein, we’ve identified a relatively under-the-radar growth stock profiting from the rise of AI, available for free through this link.
